Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 79 Pages
Report ld: 4522872
Request Sample
Customized Report
The global Prilocaine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Prilocaine is a kind of amide local anesthetic, the anesthetic intensity and speed are similar to lidocaine, but the duration is longer, and the effect on vascular dilatation is weaker. Toxicity is lower than Ridoka. Clinical use for local anesthesia, especially for patients who avoid epinephrine.
The North America Prilocaine market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Prilocaine include Active Biopharma Corp, Anant Pharmaceuticals, B. Braun, ANXIN PHARMACEUTICAL, Beijing Vokai Biotechnology, Yeasen Biotechnology, Nanjing HuaNuo Bio-Pharmaceutical Technology, Haisco Pharmaceutical Group, Adooq Bioscience, Silverline Chemicals, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Prilocaine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Prilocaine market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 2% Solution in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Private Hospital in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Prilocaine value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Prilocaine Product Scope
1.2 Prilocaine by Type
1.2.1 Global Prilocaine Sales by Type (2020 & 2024 & 2031)
1.2.2 1% Solution
1.2.3 2% Solution
1.2.4 3% Solution
1.2.5 Other
1.3 Prilocaine by Application
1.3.1 Global Prilocaine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Public Hospital
1.3.3 Private Hospital
1.4 Global Prilocaine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Prilocaine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Prilocaine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Prilocaine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Prilocaine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Prilocaine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Prilocaine Sales Market Share by Region (2020-2025)
2.2.2 Global Prilocaine Revenue Market Share by Region (2020-2025)
2.3 Global Prilocaine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Prilocaine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Prilocaine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Prilocaine Market Size and Prospective (2020-2031)
2.4.2 Europe Prilocaine Market Size and Prospective (2020-2031)
2.4.3 China Prilocaine Market Size and Prospective (2020-2031)
2.4.4 Japan Prilocaine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Prilocaine Historic Market Review by Type (2020-2025)
3.1.1 Global Prilocaine Sales by Type (2020-2025)
3.1.2 Global Prilocaine Revenue by Type (2020-2025)
3.1.3 Global Prilocaine Price by Type (2020-2025)
3.2 Global Prilocaine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Prilocaine Sales Forecast by Type (2026-2031)
3.2.2 Global Prilocaine Revenue Forecast by Type (2026-2031)
3.2.3 Global Prilocaine Price Forecast by Type (2026-2031)
3.3 Different Types Prilocaine Representative Players
4 Global Market Size by Application
4.1 Global Prilocaine Historic Market Review by Application (2020-2025)
4.1.1 Global Prilocaine Sales by Application (2020-2025)
4.1.2 Global Prilocaine Revenue by Application (2020-2025)
4.1.3 Global Prilocaine Price by Application (2020-2025)
4.2 Global Prilocaine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Prilocaine Sales Forecast by Application (2026-2031)
4.2.2 Global Prilocaine Revenue Forecast by Application (2026-2031)
4.2.3 Global Prilocaine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Prilocaine Application
5 Competition Landscape by Players
5.1 Global Prilocaine Sales by Players (2020-2025)
5.2 Global Top Prilocaine Players by Revenue (2020-2025)
5.3 Global Prilocaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prilocaine as of 2024)
5.4 Global Prilocaine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Prilocaine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Prilocaine, Product Type & Application
5.7 Global Key Manufacturers of Prilocaine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Prilocaine Sales by Company
6.1.1.1 North America Prilocaine Sales by Company (2020-2025)
6.1.1.2 North America Prilocaine Revenue by Company (2020-2025)
6.1.2 North America Prilocaine Sales Breakdown by Type (2020-2025)
6.1.3 North America Prilocaine Sales Breakdown by Application (2020-2025)
6.1.4 North America Prilocaine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Prilocaine Sales by Company
6.2.1.1 Europe Prilocaine Sales by Company (2020-2025)
6.2.1.2 Europe Prilocaine Revenue by Company (2020-2025)
6.2.2 Europe Prilocaine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Prilocaine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Prilocaine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Prilocaine Sales by Company
6.3.1.1 China Prilocaine Sales by Company (2020-2025)
6.3.1.2 China Prilocaine Revenue by Company (2020-2025)
6.3.2 China Prilocaine Sales Breakdown by Type (2020-2025)
6.3.3 China Prilocaine Sales Breakdown by Application (2020-2025)
6.3.4 China Prilocaine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Prilocaine Sales by Company
6.4.1.1 Japan Prilocaine Sales by Company (2020-2025)
6.4.1.2 Japan Prilocaine Revenue by Company (2020-2025)
6.4.2 Japan Prilocaine Sales Breakdown by Type (2020-2025)
6.4.3 Japan Prilocaine Sales Breakdown by Application (2020-2025)
6.4.4 Japan Prilocaine Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Active Biopharma Corp
7.1.1 Active Biopharma Corp Company Information
7.1.2 Active Biopharma Corp Business Overview
7.1.3 Active Biopharma Corp Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Active Biopharma Corp Prilocaine Products Offered
7.1.5 Active Biopharma Corp Recent Development
7.2 Anant Pharmaceuticals
7.2.1 Anant Pharmaceuticals Company Information
7.2.2 Anant Pharmaceuticals Business Overview
7.2.3 Anant Pharmaceuticals Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Anant Pharmaceuticals Prilocaine Products Offered
7.2.5 Anant Pharmaceuticals Recent Development
7.3 B. Braun
7.3.1 B. Braun Company Information
7.3.2 B. Braun Business Overview
7.3.3 B. Braun Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 B. Braun Prilocaine Products Offered
7.3.5 B. Braun Recent Development
7.4 ANXIN PHARMACEUTICAL
7.4.1 ANXIN PHARMACEUTICAL Company Information
7.4.2 ANXIN PHARMACEUTICAL Business Overview
7.4.3 ANXIN PHARMACEUTICAL Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 ANXIN PHARMACEUTICAL Prilocaine Products Offered
7.4.5 ANXIN PHARMACEUTICAL Recent Development
7.5 Beijing Vokai Biotechnology
7.5.1 Beijing Vokai Biotechnology Company Information
7.5.2 Beijing Vokai Biotechnology Business Overview
7.5.3 Beijing Vokai Biotechnology Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Beijing Vokai Biotechnology Prilocaine Products Offered
7.5.5 Beijing Vokai Biotechnology Recent Development
7.6 Yeasen Biotechnology
7.6.1 Yeasen Biotechnology Company Information
7.6.2 Yeasen Biotechnology Business Overview
7.6.3 Yeasen Biotechnology Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Yeasen Biotechnology Prilocaine Products Offered
7.6.5 Yeasen Biotechnology Recent Development
7.7 Nanjing HuaNuo Bio-Pharmaceutical Technology
7.7.1 Nanjing HuaNuo Bio-Pharmaceutical Technology Company Information
7.7.2 Nanjing HuaNuo Bio-Pharmaceutical Technology Business Overview
7.7.3 Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Nanjing HuaNuo Bio-Pharmaceutical Technology Prilocaine Products Offered
7.7.5 Nanjing HuaNuo Bio-Pharmaceutical Technology Recent Development
7.8 Haisco Pharmaceutical Group
7.8.1 Haisco Pharmaceutical Group Company Information
7.8.2 Haisco Pharmaceutical Group Business Overview
7.8.3 Haisco Pharmaceutical Group Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Haisco Pharmaceutical Group Prilocaine Products Offered
7.8.5 Haisco Pharmaceutical Group Recent Development
7.9 Adooq Bioscience
7.9.1 Adooq Bioscience Company Information
7.9.2 Adooq Bioscience Business Overview
7.9.3 Adooq Bioscience Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Adooq Bioscience Prilocaine Products Offered
7.9.5 Adooq Bioscience Recent Development
7.10 Silverline Chemicals
7.10.1 Silverline Chemicals Company Information
7.10.2 Silverline Chemicals Business Overview
7.10.3 Silverline Chemicals Prilocaine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Silverline Chemicals Prilocaine Products Offered
7.10.5 Silverline Chemicals Recent Development
8 Prilocaine Manufacturing Cost Analysis
8.1 Prilocaine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Prilocaine
8.4 Prilocaine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Prilocaine Distributors List
9.3 Prilocaine Customers
10 Prilocaine Market Dynamics
10.1 Prilocaine Industry Trends
10.2 Prilocaine Market Drivers
10.3 Prilocaine Market Challenges
10.4 Prilocaine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Prilocaine market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 142
USD 4900.00
(Single User License)
The global Prilocaine market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 78
USD 4250.00
(Single User License)
The global market for Prilocaine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 109
USD 3950.00
(Single User License)
The global Prilocaine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 128
USD 2900.00
(Single User License)
The global Prilocaine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 142
USD 4900.00
(Single User License)
The global market for Prilocaine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 103
USD 3950.00
(Single User License)
The global market for Prilocaine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 92
USD 2900.00
(Single User License)
Prilocaine is a kind of amide local anesthetic, the anesthetic intensity and speed are similar to lidocaine, but the duration is longer, and the effect on vascular dilatation is weaker. Toxicity is lower than Ridoka. Clinical use for local anesthesia, especially for patients who avoid epinephrine.
Published Date: 2024-09-26
Pages: 89
USD 2900.00
(Single User License)
Prilocaine is a kind of amide local anesthetic, the anesthetic intensity and speed are similar to lidocaine, but the duration is longer, and the effect on vascular dilatation is weaker. Toxicity is lower than Ridoka. Clinical use for local anesthesia, especially for patients who avoid epinephrine.
Published Date: 2024-09-26
Pages: 105
USD 4350.00
(Single User License)
Prilocaine is a kind of amide local anesthetic, the anesthetic intensity and speed are similar to lidocaine, but the duration is longer, and the effect on vascular dilatation is weaker. Toxicity is lower than Ridoka. Clinical use for local anesthesia, especially for patients who avoid epinephrine.
Published Date: 2024-09-26
Pages: 137
USD 4900.00
(Single User License)
The global Prilocaine market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 142
The global Prilocaine market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 78
The global market for Prilocaine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 109
The global Prilocaine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 128
The global Prilocaine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 142
The global market for Prilocaine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 103
The global market for Prilocaine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 92
Prilocaine is a kind of amide local anesthetic, the anesthetic intensity and speed are similar to lidocaine, but the duration is longer, and the effect on vascular dilatation is weaker. Toxicity is lower than Ridoka. Clinical use for local anesthesia, especially for patients who avoid epinephrine.
Published: 2024-09-26
Pages: 89
Prilocaine is a kind of amide local anesthetic, the anesthetic intensity and speed are similar to lidocaine, but the duration is longer, and the effect on vascular dilatation is weaker. Toxicity is lower than Ridoka. Clinical use for local anesthesia, especially for patients who avoid epinephrine.
Published: 2024-09-26
Pages: 105
Prilocaine is a kind of amide local anesthetic, the anesthetic intensity and speed are similar to lidocaine, but the duration is longer, and the effect on vascular dilatation is weaker. Toxicity is lower than Ridoka. Clinical use for local anesthesia, especially for patients who avoid epinephrine.
Published: 2024-09-26
Pages: 137
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now